Best practice

Initiative against stroke expands to 38 countries

Boehringer Ingelheim and its partners provide multidisciplinary stroke support

Explore further

How we measure

How we measure

The Index evaluates pharmaceutical companies in areas where they have the biggest potential and responsibility to make change, such as R&D and pricing. Find out more about the analytical framework and areas of evaluation.

Get in touch

Back to top |